GRDN Fair Value Estimate
$71.3995.0% undervalued
Blended fair value estimate based on DCF, Graham Number, and earnings-based models.
Guardian Pharmacy Services Inc
Exchange: NYSESector: HealthcareIndustry: Medical Care Facilities
Guardian Pharmacy Services Inc
Current Price
$36.61
+0.94%GoodMoat Value
$71.39
95.0% undervaluedProfile
Valuation (TTM)
Market Cap$2.32B
P/E43.68
EV—
P/B11.27
Shares Out63.32M
P/Sales1.59
Revenue$1.46B
EV/EBITDA22.42
Guardian Pharmacy Services Inc (GRDN) Valuation
GRDN Valuation Metrics
FCF$80.71M
FCF Growth Rate36.47%
EPS Growth (CAGR)11.59%
WACC10.00%
Fair Value Models
Graham Number, PEG-based, and Earnings-based models
View Fair Value →GRDN Valuation & Fair Value Analysis
Guardian Pharmacy Services Inc (GRDN) valuation analysis using multiple fair value methodologies. GoodMoat calculates a blended fair value target using discounted cash flow (DCF) analysis, the Graham Number, and earnings-based valuation models.
The GoodMoat Fair Value target for Guardian Pharmacy Services Inc is $71.39. The current stock price is $36.61, suggesting the stock is 95.0% undervalued.
The price-to-earnings (P/E) ratio is 43.68. Price-to-book ratio is 11.27. Price-to-sales ratio is 1.59. Enterprise value to EBITDA is 22.42. PEG ratio is 1.09.
GoodMoat's valuation models include the Graham Number (based on EPS and book value), an earnings-based model (discounted future EPS), and a PEG-adjusted valuation. The three models are averaged to produce a blended fair value estimate. Use these tools alongside the DCF calculator and reverse DCF to form a comprehensive view of Guardian Pharmacy Services Inc's intrinsic value.